Menu
06/11/2006
120 Jobs Boost For Tipperary
Pharmaceuticals company Merck Sharp & Dohme has announced that 120 jobs are to be created at its Tipperary plant.
Minister for Enterprise, Trade & Employment Micheál Martin announced a major new investment for South Tipperary. Merck Sharp & Dohme
The company are to invest €100 in the creation of further research and development initiatives at a Formulation R&D and Manufacturing Facility at its plant in Ballydine with the support of IDA Ireland.
Merck Sharp & Dohme’s (MSD) operation at Ballydine was established in 1976 and employs 340 people. It is a large-scale plant producing active pharmaceutical ingredients for use in pharmaceutical manufacturing by Merck & Co., Inc. subsidiaries throughout the world. In recent years, a second affiliate was established in Dublin dedicated to clinical research, regulatory affairs, marketing and sales operations.
The new investment will involve two specific areas of activity. A research and development (R&D) centre will develop innovative platforms for the formulation of products used in late stage clinical trials. The new pharmaceutical manufacturing facility will enable the Ballydine plant to produce tablets and capsules for a number of new products in late stage clinical trials and for new products launched on the market. This investment of €100 million will create 120 new positions over the next three years, including approximately 60 R&D positions.
Welcoming the investment Minister Martin said: “Today’s announcement is very welcome news for the people of Tipperary and the region. We are delighted that the MSD plant in Ballydine is performing to such a level that it was selected for this cutting-edge R&D and clinical trials manufacturing facility. The number of high level positions which will be created reflects the significant scale of the R&D investment. The new facility will be strategically important to Merck & Co., Inc's worldwide operations and will greatly enhance the company's future in South Tipperary."
Dr Michael P Thien, Vice President of Global Pharmaceutical Commercialisation for Merck & Co., Inc., said the investment was essential to Merck's commercialisation initiative that will bring new medicines to market more quickly and flexibly.
He added that the decision to locate a facility in Ballydine was based on a “number of factors” including "the consistent support and encouragement we received from the Irish Government, the availability of skills in the industry necessary for an operation of this level and a supportive business environment in which to operate."
(SP)
Minister for Enterprise, Trade & Employment Micheál Martin announced a major new investment for South Tipperary. Merck Sharp & Dohme
The company are to invest €100 in the creation of further research and development initiatives at a Formulation R&D and Manufacturing Facility at its plant in Ballydine with the support of IDA Ireland.
Merck Sharp & Dohme’s (MSD) operation at Ballydine was established in 1976 and employs 340 people. It is a large-scale plant producing active pharmaceutical ingredients for use in pharmaceutical manufacturing by Merck & Co., Inc. subsidiaries throughout the world. In recent years, a second affiliate was established in Dublin dedicated to clinical research, regulatory affairs, marketing and sales operations.
The new investment will involve two specific areas of activity. A research and development (R&D) centre will develop innovative platforms for the formulation of products used in late stage clinical trials. The new pharmaceutical manufacturing facility will enable the Ballydine plant to produce tablets and capsules for a number of new products in late stage clinical trials and for new products launched on the market. This investment of €100 million will create 120 new positions over the next three years, including approximately 60 R&D positions.
Welcoming the investment Minister Martin said: “Today’s announcement is very welcome news for the people of Tipperary and the region. We are delighted that the MSD plant in Ballydine is performing to such a level that it was selected for this cutting-edge R&D and clinical trials manufacturing facility. The number of high level positions which will be created reflects the significant scale of the R&D investment. The new facility will be strategically important to Merck & Co., Inc's worldwide operations and will greatly enhance the company's future in South Tipperary."
Dr Michael P Thien, Vice President of Global Pharmaceutical Commercialisation for Merck & Co., Inc., said the investment was essential to Merck's commercialisation initiative that will bring new medicines to market more quickly and flexibly.
He added that the decision to locate a facility in Ballydine was based on a “number of factors” including "the consistent support and encouragement we received from the Irish Government, the availability of skills in the industry necessary for an operation of this level and a supportive business environment in which to operate."
(SP)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
23 April 2004
Merck investment to create 80 new jobs
The world's third largest pharmaceutical company has announced it is to invest €5 million and create 80 jobs at a new Irish operation in Co Dublin. Merck & Co.
Merck investment to create 80 new jobs
The world's third largest pharmaceutical company has announced it is to invest €5 million and create 80 jobs at a new Irish operation in Co Dublin. Merck & Co.
10 February 2015
Purepipe To Create Six New Jobs
Belfast-based Purepipe is investing £250,000 and creating six new jobs as part of plans to boost sales in Great Britain and the Republic of Ireland. Invest Northern Ireland has offered the company £45,000 towards its expansion which involves investing in new state-of-the-art specialised pipe manufacturing equipment needed to target new business.
Purepipe To Create Six New Jobs
Belfast-based Purepipe is investing £250,000 and creating six new jobs as part of plans to boost sales in Great Britain and the Republic of Ireland. Invest Northern Ireland has offered the company £45,000 towards its expansion which involves investing in new state-of-the-art specialised pipe manufacturing equipment needed to target new business.
24 March 2009
Pharma Jobs Boost For Carlow
Around 60 new jobs are to be created in Carlow by the pharmaceutical facility, Merck Sharp & Dohme. The recession-beating jobs are the result of the construction of a new €20m vaccines and biologics facility in the town this year. The firm says 170 people will be employed when the facility opens in 2011.
Pharma Jobs Boost For Carlow
Around 60 new jobs are to be created in Carlow by the pharmaceutical facility, Merck Sharp & Dohme. The recession-beating jobs are the result of the construction of a new €20m vaccines and biologics facility in the town this year. The firm says 170 people will be employed when the facility opens in 2011.
22 June 2006
Combilift To Create 100 New Jobs
Irish Minister for Enterprise, Trade and Employment Micheal Martin officially opened the new 10 million euro headquarters of Irish company Combilift in Monaghan town, which will create 100 new jobs over the next three years bringing total staff numbers to 250.
Combilift To Create 100 New Jobs
Irish Minister for Enterprise, Trade and Employment Micheal Martin officially opened the new 10 million euro headquarters of Irish company Combilift in Monaghan town, which will create 100 new jobs over the next three years bringing total staff numbers to 250.
07 August 2013
New High-Tech Investment Creates 25 New Jobs
Minister for Research and Innovation, Seán Sherlock TD, has welcomed the announcement by Swiss company u-blox that it is to invest €1m in a new Cork operation, which will design microchips for use in Global Positioning Systems (GPS). The new facility will be located in Riverview Business Park in Mahon, Cork City.
New High-Tech Investment Creates 25 New Jobs
Minister for Research and Innovation, Seán Sherlock TD, has welcomed the announcement by Swiss company u-blox that it is to invest €1m in a new Cork operation, which will design microchips for use in Global Positioning Systems (GPS). The new facility will be located in Riverview Business Park in Mahon, Cork City.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
